DK0871467T3 - Ny formulering til afgivelse af peptid - Google Patents

Ny formulering til afgivelse af peptid

Info

Publication number
DK0871467T3
DK0871467T3 DK96917292T DK96917292T DK0871467T3 DK 0871467 T3 DK0871467 T3 DK 0871467T3 DK 96917292 T DK96917292 T DK 96917292T DK 96917292 T DK96917292 T DK 96917292T DK 0871467 T3 DK0871467 T3 DK 0871467T3
Authority
DK
Denmark
Prior art keywords
formulation
peptide
delivery
new formulation
deslorelin
Prior art date
Application number
DK96917292T
Other languages
English (en)
Inventor
John Desmond Walsh
Timothy Elliot Trigg
Original Assignee
Peptech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptech Ltd filed Critical Peptech Ltd
Application granted granted Critical
Publication of DK0871467T3 publication Critical patent/DK0871467T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DK96917292T 1995-06-20 1996-06-20 Ny formulering til afgivelse af peptid DK0871467T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN3667A AUPN366795A0 (en) 1995-06-20 1995-06-20 Formulation for preventing reproductive function
PCT/AU1996/000370 WO1997000693A1 (en) 1995-06-20 1996-06-20 Novel formulation for peptide release

Publications (1)

Publication Number Publication Date
DK0871467T3 true DK0871467T3 (da) 2002-12-23

Family

ID=3788008

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96917292T DK0871467T3 (da) 1995-06-20 1996-06-20 Ny formulering til afgivelse af peptid

Country Status (17)

Country Link
US (2) US5925619A (da)
EP (1) EP0871467B1 (da)
JP (1) JP4016133B2 (da)
CN (1) CN1145496C (da)
AT (1) ATE223726T1 (da)
AU (2) AUPN366795A0 (da)
CA (1) CA2225796C (da)
DE (2) DE122008000004I2 (da)
DK (1) DK0871467T3 (da)
ES (1) ES2182983T3 (da)
FR (1) FR08C0001I2 (da)
HK (1) HK1014874A1 (da)
NL (1) NL300330I2 (da)
NZ (1) NZ309697A (da)
PT (1) PT871467E (da)
SI (1) SI0871467T1 (da)
WO (1) WO1997000693A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function
ES2285737T3 (es) * 1996-08-30 2007-11-16 Peptech Limited Formula de liberacion prolongada de los agonistas y analogos peptidicos de gnrh.
BR9912275A (pt) * 1998-07-20 2001-04-17 Peptech Ltd Formulação de bioimplante
US8052982B2 (en) * 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
US6211221B1 (en) * 1999-04-05 2001-04-03 Johnny W. Peterson Dietary supplement containing histidine for alleviating dysmenorrhea, endometriosis, and pre-term labor
JP2004512369A (ja) * 2000-10-30 2004-04-22 ユニバーシティ・オブ・チューリッヒ 尿失禁の治療のためのｇｎｒｈアナログ
GB0221539D0 (en) * 2002-09-17 2002-10-23 Medical Res Council Methods of treatment
JP2007517042A (ja) * 2003-12-30 2007-06-28 デュレクト コーポレーション 活性物質、好ましくはｇｎｒｈの制御放出のための、好ましくはｐｅｇおよびｐｌｇの混合物を含有するポリマーインプラント
CA2590239A1 (en) * 2004-12-23 2006-07-06 Durect Corporation Controlled release compositions
US20100234306A1 (en) * 2007-09-11 2010-09-16 Dorian Bevec Use of a peptide as a therapeutic agent
DE102008015104A1 (de) 2008-03-19 2009-09-24 Basf Coatings Ag Beschichtungszusammensetzung, Verfahren zu ihrer Herstellung, ihre Verwendung und mit ihr beschichtete Substrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS563846B2 (da) * 1972-10-12 1981-01-27
US4218439A (en) * 1977-07-14 1980-08-19 The Salk Institute For Biological Studies Peptide which inhibits gonadal function
US4256737A (en) * 1979-06-11 1981-03-17 Syntex (U.S.A.) Inc. Long acting depot injectable formulations for LH-RH analogues
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
ES2039219T3 (es) * 1986-08-11 1993-09-16 American Cyanamid Company Composiciones para administracion parenteral y su uso.
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
WO1993015722A1 (en) * 1992-02-07 1993-08-19 Syntex (Usa) Inc. Controlled delivery of pharmaceuticals from preformed porous microparticles
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function

Also Published As

Publication number Publication date
FR08C0001I1 (da) 2008-03-21
ES2182983T3 (es) 2003-03-16
SI0871467T1 (en) 2003-08-31
DE69623652T2 (de) 2003-05-28
DE122008000004I2 (de) 2009-08-06
JP4016133B2 (ja) 2007-12-05
EP0871467B1 (en) 2002-09-11
NL300330I2 (nl) 2008-04-01
PT871467E (pt) 2002-12-31
EP0871467A4 (en) 2000-07-05
DE122008000004I1 (de) 2008-04-17
CA2225796A1 (en) 1997-01-09
EP0871467A1 (en) 1998-10-21
FR08C0001I2 (da) 2009-11-20
CN1145496C (zh) 2004-04-14
US5925619A (en) 1999-07-20
AU5992796A (en) 1997-01-22
ATE223726T1 (de) 2002-09-15
US6211152B1 (en) 2001-04-03
AU701837B2 (en) 1999-02-04
WO1997000693A1 (en) 1997-01-09
DE69623652D1 (de) 2002-10-17
AUPN366795A0 (en) 1995-07-13
JP2001521482A (ja) 2001-11-06
CN1188414A (zh) 1998-07-22
NL300330I1 (nl) 2008-03-03
CA2225796C (en) 2011-09-20
HK1014874A1 (en) 1999-10-08
NZ309697A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
FR08C0001I2 (da)
DK0742714T3 (da) Flydende farmaceutiske præparater omfattende thyroideahormoner
AU4718496A (en) Use of aerogels in agriculture
NO931766D0 (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
FI962154A0 (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
ES2184895T3 (es) Sistema no polimerico de administracion con liberacion retardada.
MY113488A (en) Compounds with growth hormone releasing properties
DE69531741D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
FI963696A (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
HK1038310A1 (en) Compositions and methods for treating intracellular infections.
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
OA09771A (en) Asphodelus composition for increasing white blood cell count.
MX9803093A (es) Suministro de polipeptidos biologicamente activos.
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.